Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review
March 2, 2026
In this podcast, Dr. Gretchen Ray and Dr. Joe Anderson discuss the AJHP Clinical Research Report "Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
SPEAKERS
Gretchen Ray, PharmD, PhC, BCACP, CDCES is an associate professor of pharmacy practice at the University of New Mexico College of Pharmacy. Her clinical practice is within a family medicine clinic where she practices as a pharmacist clinician and certified diabetes care and education specialist providing diabetes and cardiovascular risk reduction medication therapy management to high-risk patients. She is a hub team member on the UNM Endocrinology teleECHO clinic and is the residency program director for the UNM Ambulatory Care PGY2 pharmacy residency.
Joe R. Anderson, Pharm.D., PhC is the associate dean for professional education and associate professor of pharmacy practice with the University of New Mexico College of Pharmacy (COP). He has been employed by the COP since 1999. He is licensed as a pharmacist clinician and practices at the UNM HF Clinic. His research interests are in cardiovascular pharmacotherapy (specifically HF, primary and secondary ASCVD prevention, and atrial fibrillation) and health outcomes, particularly pertaining to advanced pharmacist practice.
Daniel J. Cobaugh, Pharm.D., FAACT, DABAT is the senior vice president of professional development and publishing at ASHP and the editor-in-chief of AJHP. He has served on the ASHP staff since 2002. He received his B.S. in Pharmacy from the University of Pittsburgh and his Doctor of Pharmacy from Duquesne University. Cobaugh completed an ASHP-accredited residency in hospital pharmacy at Mercy Hospital of Pittsburgh and a clinical toxicology fellowship at the Pittsburgh Poison Center. He practiced as pharmacist-clinical toxicologist and held faculty appointments at the University of Pittsburgh Medical Center and the University of Rochester Medical Center.
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ADVERTISEMENT